Recent Additions

This page includes the documents that were newly added to the repository within the last 30 days.

All these words:

This exact word or phrase:

Any of these words:

None of these words:

Language:

Visit our Help Page for additional assistance

Select a Range:

Select a Format:

Custom Search Builder:

Custom Search Box

Visit our Help Page for additional assistance

Showing 761 - 780 of 1969 results

The San Diego Consensus For Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease.

Yadlapati, Rena ;

Weissbrod, Philip

February 2026 | The American Journal of Gastroenterology, 2026, v. 121, no. 2

The term laryngopharyngeal reflux (LPR) is frequently applied to aerodigestive symptoms despite lack of objective reflux evidence. The aim of this initiative was to develop a modern care paradigm for LPR supported by otolaryngology and gastroenterology disciplines.A 28-member international interdisciplinary working group developed practical stateme ...

10/09/2026

Supporting Files

Title : The San Diego Consensus For Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease. Personal Author(s) : Yadlapati, Rena;Weissbrod, Philip;Walsh, Erin;Carroll, Thomas L.;Chan, Walter W;Gartner-Schmidt, Jackie;Guadagnoli, Livia;Jette, Marie;Myers, Jennifer C;O'Rourke, Ashli;Sweis, Rami;Wu, Justin;Barkmeier-Kraemer, Julie M;Cates, Daniel;Chen, Chien-Lin;Coss-Adame, Enrique;Dion, Gregory;Francis, David;Kaneko, Mami;Lechien, Jerome R.;Misono, Stephanie;Rameau, Anais;Roman, Sabine;Vertigan, Anne;Xiao, Yinglian;Zerbib, Frank;Greytak, Madeline;Pandolfino, John E.;Gyawali, C Prakash; Published Date : February 2026 Pages in Document : 322-336 (31 pdf pages) Source : The American Journal of Gastroenterology, 2026, v. 121, no. 2 DOI : https://doi.org/10.14309/ajg.0000000000003482 Journal Title : The American Journal of Gastroenterology
Yadlapati, R., Weissbrod, P., Walsh, E., Carroll, T. L., Chan, W. W., Gartner-Schmidt, J., Guadagnoli, L., Jette, M., Myers, J. C., O'Rourke, A., Sweis, R., Wu, J., Barkmeier-Kraemer, J. M., Cates, D., Chen, C. L., Coss-Adame, E., Dion, G., Francis, D., Kaneko, M., ... Gyawali, C. P. (2026). The San Diego Consensus For Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease. The American Journal of Gastroenterology, 121(2). https://doi.org/10.14309/ajg.0000000000003482

Yadlapati, Rena, Philip Weissbrod, Erin Walsh, Thomas L. Carroll, Walter W Chan, Jackie Gartner-Schmidt, and Livia Guadagnoli, et al.. "The San Diego Consensus For Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease." The American Journal of Gastroenterology 121, no. 2 (2026). https://doi.org/10.14309/ajg.0000000000003482.

Yadlapati, Rena, et al. "The San Diego Consensus For Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease." The American Journal of Gastroenterology, vol. 121, no. 2, 2026. Stacks. https://doi.org/10.14309/ajg.0000000000003482.
Export RIS Citation Information. TY - Journal Article AU - Yadlapati, Rena AU - Weissbrod, Philip AU - Walsh, Erin AU - Carroll, Thomas L. AU - Chan, Walter W AU - Gartner-Schmidt, Jackie AU - Guadagnoli, Livia AU - Jette, Marie AU - Myers, Jennifer C AU - O'Rourke, Ashli AU - Sweis, Rami AU - Wu, Justin AU - Barkmeier-Kraemer, Julie M AU - Cates, Daniel AU - Chen, Chien-Lin AU - Coss-Adame, Enrique AU - Dion, Gregory AU - Francis, David AU - Kaneko, Mami AU - Lechien, Jerome R. AU - Misono, Stephanie AU - Rameau, Anais AU - Roman, Sabine AU - Vertigan, Anne AU - Xiao, Yinglian AU - Zerbib, Frank AU - Greytak, Madeline AU - Pandolfino, John E. AU - Gyawali, C Prakash AB - The term laryngopharyngeal reflux (LPR) is frequently applied to aerodigestive symptoms despite lack of objective reflux evidence. The aim of this initiative was to develop a modern care paradigm for LPR supported by otolaryngology and gastroenterology disciplines. AB - A 28-member international interdisciplinary working group developed practical statements within the following domains: definition/terminology, initial diagnostic evaluation, reflux monitoring, therapeutic trials, behavioral factors and therapy, and risk stratification. Literature reviews guided statement development and were presented at virtual/in-person meetings. Each statement underwent 2 or more rounds of voting per the RAND Appropriateness Method; statements reaching appropriateness with ≥80% agreement are included as recommendations. AB - The term laryngopharyngeal symptoms (LPS) applies to aerodigestive symptoms with potential to be induced by reflux and include cough, voice change, throat clearing, excess throat phlegm, and throat pain. Laryngopharyngeal reflux disease (LPRD) refers to patients with LPS and objective evidence of reflux. Importantly, the presence of LPS does not equate to LPRD. Laryngoscopy has value in assessing for nonreflux laryngopharyngeal processes, but laryngoscopic findings alone cannot diagnose LPRD. LPS patients should be categorized as with or without concurrent esophageal reflux symptoms. While lifestyle modification and empiric trials of acid suppression ± alginates are appropriate when esophageal reflux symptoms coexist, upper endoscopy and ambulatory reflux monitoring are required for LPRD diagnosis when symptoms persist, when LPS is isolated, or when management needs to be escalated to include invasive antireflux management. The two recommended ambulatory reflux monitoring modalities, 24-hour pH-impedance and 96-hour wireless pH monitoring, are not mutually exclusive with distinct roles for the evaluation of LPS. Laryngeal hyperresponsiveness and hypervigilance commonly contribute to both LPS and LPRD presentations and are responsive to laryngeal recalibration therapy and neuromodulators. AB - The San Diego Consensus represents the formal modern-day interdisciplinary care paradigm to evaluate and manage LPS and LPRD. AB - Author manuscript AN - cdc:261502 C4 - PMC12353988 DO - https://doi.org/10.14309/ajg.0000000000003482 IS - 2 J2 - The American Journal of Gastroenterology KW - Pharyngitis KW - Laryngoscopy KW - Proton Pump Inhibitors KW - Humans KW - Cough KW - Laryngopharyngeal Reflux KW - Esophageal pH Monitoring KW - Humans KW - Laryngopharyngeal Reflux KW - Laryngoscopy KW - Proton Pump Inhibitors KW - Esophageal pH Monitoring KW - Cough KW - Pharyngitis LA - eng PY - 2026 T2 - The American Journal of Gastroenterology T2 - The American Journal of Gastroenterology, 2026, v. 121, no. 2 TI - The San Diego Consensus For Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease. VL - 121 UR - https://stacks.cdc.gov/view/cdc/261502 ER -
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024.

Lewis, Nathaniel M. ;

Harker, Elizabeth J.

Oct-15-2025 | The Journal of Infectious Diseases, Oct-15-2025, v. 232, no. 4

The 2023-2024 influenza season included sustained elevated activity from December 2023 to February 2024 and continued activity through May 2024. Influenza A(H1N1), A(H3N2), and B viruses circulated during the season.During 1 September 2023 to 31 May 2024, a multistate sentinel surveillance network of 24 medical centers in 20 US states enrolled adul ...

10/09/2026

Supporting Files

Title : Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. Personal Author(s) : Lewis, Nathaniel M.;Harker, Elizabeth J.;Cleary, Seana;Zhu, Yuwei;Grijalva, Carlos G.;Chappell, James D.;Rhoads, Jillian P.;Baughman, Adrienne;Casey, Jonathan D.;Blair, Paul W.;Jones, Ian D.;Johnson, Cassandra A.;Halasa, Natasha B.;Lauring, Adam S.;Martin, Emily T.;Gaglani, Manju;Ghamande, Shekhar;Columbus, Cristie;Steingrub, Jay S.;Duggal, Abhijit;Felzer, Jamie R.;Prekker, Matthew E.;Peltan, Ithan D.;Brown, Samuel M.;Hager, David N.;Gong, Michelle N.;Mohamed, Amira;Exline, Matthew C.;Khan, Akram;Ferguson, Samantha A.N.;Mosier, Jarrod;Qadir, Nida;Chang, Steven Y.;Ginde, Adit A.;Zepeski, Anne;Mallow, Christopher;Harris, Estelle S.;Johnson, Nicholas J.;Gibbs, Kevin W.;Kwon, Jennie H.;Vaughn, Ivana A.;Ramesh, Mayur;Safdar, Basmah;Surie, Diya;Dawood, Fatimah S.;Ellington, Sascha;Self, Wesley H.; Published Date : Oct-15-2025 Pages in Document : e626-e636 (19 pdf pages) Source : The Journal of Infectious Diseases, Oct-15-2025, v. 232, no. 4 DOI : https://doi.org/10.1093/infdis/jiaf185 Journal Title : The Journal of Infectious Diseases
Lewis, N. M., Harker, E. J., Cleary, S., Zhu, Y., Grijalva, C. G., Chappell, J. D., Rhoads, J. P., Baughman, A., Casey, J. D., Blair, P. W., Jones, I. D., Johnson, C. A., Halasa, N. B., Lauring, A. S., Martin, E. T., Gaglani, M., Ghamande, S., Columbus, C., Steingrub, J. S., ... Self, W. H. (2025). Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. The Journal of Infectious Diseases, 232(4). https://doi.org/10.1093/infdis/jiaf185

Lewis, Nathaniel M., Elizabeth J. Harker, Seana Cleary, Yuwei Zhu, Carlos G. Grijalva, James D. Chappell, and Jillian P. Rhoads, et al.. "Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024." The Journal of Infectious Diseases 232, no. 4 (2025). https://doi.org/10.1093/infdis/jiaf185.

Lewis, Nathaniel M., et al. "Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024." The Journal of Infectious Diseases, vol. 232, no. 4, 2025. Stacks. https://doi.org/10.1093/infdis/jiaf185.
Export RIS Citation Information. TY - Journal Article AU - Lewis, Nathaniel M. AU - Harker, Elizabeth J. AU - Cleary, Seana AU - Zhu, Yuwei AU - Grijalva, Carlos G. AU - Chappell, James D. AU - Rhoads, Jillian P. AU - Baughman, Adrienne AU - Casey, Jonathan D. AU - Blair, Paul W. AU - Jones, Ian D. AU - Johnson, Cassandra A. AU - Halasa, Natasha B. AU - Lauring, Adam S. AU - Martin, Emily T. AU - Gaglani, Manju AU - Ghamande, Shekhar AU - Columbus, Cristie AU - Steingrub, Jay S. AU - Duggal, Abhijit AU - Felzer, Jamie R. AU - Prekker, Matthew E. AU - Peltan, Ithan D. AU - Brown, Samuel M. AU - Hager, David N. AU - Gong, Michelle N. AU - Mohamed, Amira AU - Exline, Matthew C. AU - Khan, Akram AU - Ferguson, Samantha A.N. AU - Mosier, Jarrod AU - Qadir, Nida AU - Chang, Steven Y. AU - Ginde, Adit A. AU - Zepeski, Anne AU - Mallow, Christopher AU - Harris, Estelle S. AU - Johnson, Nicholas J. AU - Gibbs, Kevin W. AU - Kwon, Jennie H. AU - Vaughn, Ivana A. AU - Ramesh, Mayur AU - Safdar, Basmah AU - Surie, Diya AU - Dawood, Fatimah S. AU - Ellington, Sascha AU - Self, Wesley H. AB - The 2023-2024 influenza season included sustained elevated activity from December 2023 to February 2024 and continued activity through May 2024. Influenza A(H1N1), A(H3N2), and B viruses circulated during the season. AB - During 1 September 2023 to 31 May 2024, a multistate sentinel surveillance network of 24 medical centers in 20 US states enrolled adults aged ≥18 years hospitalized with acute respiratory illness. Consistent with a test-negative design, cases tested positive for influenza viruses by molecular or antigen test, and controls tested negative for influenza viruses and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Vaccine effectiveness (VE) against influenza-associated hospitalization was calculated as (1 - adjusted odds ratio for vaccination) × 100%. AB - Among 7690 patients, including 1170 influenza cases (33% vaccinated) and 6520 controls, VE was 40% (95% confidence interval [CI], 31%-48%) with varying estimates by age: 18-49 years, 53% (95% CI, 34%-67%); 50-64 years, 47% (95% CI, 31%-60%); ≥ 65 years, 31% (95% CI, 16%-43%). Protection was similar among immunocompetent patients (40%; 95% CI, 30%-49%) and immunocompromised patients (32%; 95% CI, 7%-50%). VE was statistically significant against influenza B (67%; 95% CI, 35%-84%) and A(H1N1) (36%; 95% CI, 21%-48%) and crossed the null against A(H3N2) (19%; 95% CI, -8% to 39%). VE was higher for patients 14-60 days from vaccination (54%; 95% CI, 40%-65%) than >120 days (18%; 95% CI, -1% to 33%). AB - During 2023-2024, influenza vaccination reduced the risk of influenza A(H1N1)- and influenza B-associated hospitalizations among adults; effectiveness was lower in patients vaccinated >120 days prior to illness onset compared with those vaccinated 14-60 days prior. AB - Author manuscript AN - cdc:261501 C4 - PMC13196694 DO - https://doi.org/10.1093/infdis/jiaf185 IS - 4 J2 - The Journal of Infectious Diseases KW - Adolescent KW - Female KW - Influenza B virus KW - Influenza A Virus, H1N1 Subtype KW - Vaccination KW - Aged KW - Young Adult KW - Sentinel Surveillance KW - Influenza Vaccines KW - Aged, 80 and over KW - Vaccine Efficacy KW - Hospitalization KW - Male KW - Influenza A Virus, H3N2 Subtype KW - Humans KW - Middle Aged KW - Adult KW - Influenza, Human KW - seasonal influenza KW - severe influenza KW - vaccine effectiveness KW - waning KW - hospitalization KW - Humans KW - Influenza, Human KW - Influenza A Virus, H1N1 Subtype KW - Influenza A Virus, H3N2 Subtype KW - Middle Aged KW - Hospitalization KW - Adult KW - Male KW - Female KW - Influenza Vaccines KW - Vaccine Efficacy KW - Influenza B virus KW - Aged KW - Young Adult KW - Adolescent KW - Sentinel Surveillance KW - Vaccination KW - Aged, 80 and over LA - eng PY - 2025 T2 - The Journal of Infectious Diseases T2 - The Journal of Infectious Diseases, Oct-15-2025, v. 232, no. 4 TI - Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024. VL - 232 UR - https://stacks.cdc.gov/view/cdc/261501 ER -
Availability of a Continuity of Operations Plan Toolkit For Public Health Mycobacteriology Laboratories.

Youngblood, Monica E. ;

Johnston, Stephanie P.

August 13, 2025 | Journal of Public Health Management and Practice : JPHMP, 2025, v. 31, no. 5

Interruption of service events may result in a temporary inability to use equipment or laboratory space, compromise staffing and infrastructure, preclude maintenance or calibration of equipment, and prevent or require extensive disinfection and decontamination. A continuity of operations plan allows a mycobacteriology laboratory to shift efficientl ...

10/09/2026

Supporting Files

Title : Availability of a Continuity of Operations Plan Toolkit For Public Health Mycobacteriology Laboratories. Personal Author(s) : Youngblood, Monica E.;Johnston, Stephanie P.; Published Date : August 13, 2025 Pages in Document : 783-786 (7 pdf pages) Source : Journal of Public Health Management and Practice : JPHMP, 2025, v. 31, no. 5 DOI : https://doi.org/10.1097/PHH.0000000000002157 Journal Title : Journal of Public Health Management and Practice : JPHMP
Youngblood, M. E., & Johnston, S. P. (2025). Availability of a Continuity of Operations Plan Toolkit For Public Health Mycobacteriology Laboratories. Journal of Public Health Management and Practice : JPHMP, 31(5). https://doi.org/10.1097/PHH.0000000000002157

Youngblood, Monica E. and Stephanie P. Johnston. "Availability of a Continuity of Operations Plan Toolkit For Public Health Mycobacteriology Laboratories." Journal of Public Health Management and Practice : JPHMP 31, no. 5 (2025). https://doi.org/10.1097/PHH.0000000000002157.

Youngblood, Monica E., and Stephanie P. Johnston "Availability of a Continuity of Operations Plan Toolkit For Public Health Mycobacteriology Laboratories." Journal of Public Health Management and Practice : JPHMP, vol. 31, no. 5, 2025. Stacks. https://doi.org/10.1097/PHH.0000000000002157.
Export RIS Citation Information. TY - Journal Article AU - Youngblood, Monica E. AU - Johnston, Stephanie P. AB - Interruption of service events may result in a temporary inability to use equipment or laboratory space, compromise staffing and infrastructure, preclude maintenance or calibration of equipment, and prevent or require extensive disinfection and decontamination. A continuity of operations plan allows a mycobacteriology laboratory to shift efficiently from its regular structure to one that enables timely continuation of testing services. The Continuity of Operations Plan Toolkit for Public Health Mycobacteriology Laboratories was developed to aid continuity of operations planning for mycobacteriology laboratories that offer testing services for diagnosing tuberculosis. The toolkit includes processes for creating, modifying, or implementing mycobacteriology continuity of operations plans, including considerations for leveraging partnerships. Available within the toolkit are various templates and checklists which can be adapted to meet specific local needs. While intended for public health laboratories, the toolkit is applicable for clinical, commercial, and other laboratory types that may perform tuberculosis testing. AB - Author manuscript AN - cdc:261500 C4 - PMC12344787 DO - https://doi.org/10.1097/PHH.0000000000002157 IS - 5 J2 - Journal of Public Health Management and Practice : JPHMP KW - Public Health KW - Tuberculosis KW - Humans KW - Laboratories KW - continuity of operations plan (COOP) KW - interruption of service event (ISE) KW - mycobacteriology KW - tuberculosis (TB) testing KW - Humans KW - Public Health KW - Laboratories KW - Tuberculosis LA - eng PY - 2025 T2 - Journal of Public Health Management and Practice : JPHMP T2 - Journal of Public Health Management and Practice : JPHMP, 2025, v. 31, no. 5 TI - Availability of a Continuity of Operations Plan Toolkit For Public Health Mycobacteriology Laboratories. VL - 31 UR - https://stacks.cdc.gov/view/cdc/261500 ER -
Trends in HIV Preexposure Prophylaxis Use Before and After Launch of the Ending the HIV Epidemic in the US Initiative, 2016-2023.

Zhu, Weiming ;

Huang, Ya-lin A.

August 2025 | Journal of Acquired Immune Deficiency Syndromes (1999), 2025, v. 99, no. 4

The Ending the HIV Epidemic (EHE) in the US initiative was launched by the US Department of Health and Human Services in 2019 with the goal of decreasing new HIV infections 90% by 2030. Increasing the use of HIV preexposure prophylaxis (PrEP) is one of the EHE strategies. We assessed the impact of EHE activities on PrEP use.Using IQVIA real-world l ...

10/09/2026

Supporting Files

Title : Trends in HIV Preexposure Prophylaxis Use Before and After Launch of the Ending the HIV Epidemic in the US Initiative, 2016-2023. Personal Author(s) : Zhu, Weiming;Huang, Ya-lin A.;Kourtis, Athena P.;Neblett-Fanfair, Robyn;Mermin, Jonathan;Hoover, Karen W.; Published Date : August 2025 Pages in Document : 334-340 (12 pdf pages) Source : Journal of Acquired Immune Deficiency Syndromes (1999), 2025, v. 99, no. 4 DOI : https://doi.org/10.1097/QAI.0000000000003674 Journal Title : Journal of Acquired Immune Deficiency Syndromes (1999)
Zhu, W., Huang, Y. l. A., Kourtis, A. P., Neblett-Fanfair, R., Mermin, J., & Hoover, K. W. (2025). Trends in HIV Preexposure Prophylaxis Use Before and After Launch of the Ending the HIV Epidemic in the US Initiative, 2016-2023. Journal of Acquired Immune Deficiency Syndromes (1999), 99(4). https://doi.org/10.1097/QAI.0000000000003674

Zhu, Weiming, Ya-lin A. Huang, Athena P. Kourtis, Robyn Neblett-Fanfair, Jonathan Mermin, and Karen W. Hoover. "Trends in HIV Preexposure Prophylaxis Use Before and After Launch of the Ending the HIV Epidemic in the US Initiative, 2016-2023." Journal of Acquired Immune Deficiency Syndromes (1999) 99, no. 4 (2025). https://doi.org/10.1097/QAI.0000000000003674.

Zhu, Weiming, et al. "Trends in HIV Preexposure Prophylaxis Use Before and After Launch of the Ending the HIV Epidemic in the US Initiative, 2016-2023." Journal of Acquired Immune Deficiency Syndromes (1999), vol. 99, no. 4, 2025. Stacks. https://doi.org/10.1097/QAI.0000000000003674.
Export RIS Citation Information. TY - Journal Article AU - Zhu, Weiming AU - Huang, Ya-lin A. AU - Kourtis, Athena P. AU - Neblett-Fanfair, Robyn AU - Mermin, Jonathan AU - Hoover, Karen W. AB - The Ending the HIV Epidemic (EHE) in the US initiative was launched by the US Department of Health and Human Services in 2019 with the goal of decreasing new HIV infections 90% by 2030. Increasing the use of HIV preexposure prophylaxis (PrEP) is one of the EHE strategies. We assessed the impact of EHE activities on PrEP use. AB - Using IQVIA real-world longitudinal prescription data and the National HIV Surveillance System data, we calculated jurisdiction-level PrEP to diagnosis ratios (PDRs) in the United States from 2016 to 2023. We assessed impact of EHE with a difference-in-difference analysis. AB - The PDR increased from 3.0 to 14.7 in EHE jurisdictions, from 1.2 to 7.2 in EHE states, and from 2.5 to 13.4 in non-EHE jurisdictions. On average, no additional increase in the PDR was found for EHE counties compared with matched non-EHE counties, (adjusted difference-in-difference: 0.2, 95% confidence interval: -1.0 to 1.3), or for EHE states (adjusted difference-in-difference: 0.4, 95% CI: -1.6 to 2.4). AB - Overall PrEP use increased markedly, with some EHE jurisdictions achieving greater increases than non-EHE jurisdictions with similar PDRs in 2019. The uneven increase in PrEP use in EHE jurisdictions underscores the need for jurisdiction-specific PrEP implementation strategies designed for the needs of each community. It also underscores the need for sufficient funding to accomplish EHE goals. AB - Author manuscript AN - cdc:261499 C4 - PMC12344591 DO - https://doi.org/10.1097/QAI.0000000000003674 IS - 4 J2 - Journal of Acquired Immune Deficiency Syndromes (1999) KW - Female KW - Epidemics KW - Anti-HIV Agents KW - Male KW - Humans KW - Adult KW - HIV Infections KW - Pre-Exposure Prophylaxis KW - ending the HIV Epidemic initiative (EHE) KW - PrEP KW - HIV KW - Humans KW - Pre-Exposure Prophylaxis KW - HIV Infections KW - Epidemics KW - Anti-HIV Agents KW - Male KW - Female KW - Adult LA - eng PY - 2025 T2 - Journal of Acquired Immune Deficiency Syndromes (1999) T2 - Journal of Acquired Immune Deficiency Syndromes (1999), 2025, v. 99, no. 4 TI - Trends in HIV Preexposure Prophylaxis Use Before and After Launch of the Ending the HIV Epidemic in the US Initiative, 2016-2023. VL - 99 UR - https://stacks.cdc.gov/view/cdc/261499 ER -
Rural-urban Disparities in Human Papillomavirus Vaccination: Findings From a Cross-sectional Survey of 13 Southern US States, December 2019-January 2020.

Vasudevan, Lavanya ;

Wang, Yunfei

March 2025 | The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association, 2025, v. 41, no. 2

Rural adolescents in the United States lag behind their urban counterparts in the uptake of the human papillomavirus (HPV) vaccine. However, a systematic assessment of factors associated with rural-urban disparities in HPV vaccination coverage to inform potential vaccination promotion interventions is lacking in the literature. Prioritizing HPV vac ...

10/09/2026

Supporting Files

Title : Rural-urban Disparities in Human Papillomavirus Vaccination: Findings From a Cross-sectional Survey of 13 Southern US States, December 2019-January 2020. Personal Author(s) : Vasudevan, Lavanya;Wang, Yunfei;Ostermann, Jan;Yelverton, Valerie;Yang, Jingyi;Fish, Laura J.;Harrison, Sayward E.;Williams, Charnetta;Walter, Emmanuel B.; Published Date : March 2025 Pages in Document : e12913 (18 pdf pages) Source : The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association, 2025, v. 41, no. 2 DOI : https://doi.org/10.1111/jrh.12913 Journal Title : The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association
Vasudevan, L., Wang, Y., Ostermann, J., Yelverton, V., Yang, J., Fish, L. J., Harrison, S. E., Williams, C., & Walter, E. B. (2025). Rural-urban Disparities in Human Papillomavirus Vaccination: Findings From a Cross-sectional Survey of 13 Southern US States, December 2019-January 2020. The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association, 41(2). https://doi.org/10.1111/jrh.12913

Vasudevan, Lavanya, Yunfei Wang, Jan Ostermann, Valerie Yelverton, Jingyi Yang, Laura J. Fish, Sayward E. Harrison, Charnetta Williams, and Emmanuel B. Walter. "Rural-urban Disparities in Human Papillomavirus Vaccination: Findings From a Cross-sectional Survey of 13 Southern US States, December 2019-January 2020." The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association 41, no. 2 (2025). https://doi.org/10.1111/jrh.12913.

Vasudevan, Lavanya, et al. "Rural-urban Disparities in Human Papillomavirus Vaccination: Findings From a Cross-sectional Survey of 13 Southern US States, December 2019-January 2020." The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association, vol. 41, no. 2, 2025. Stacks. https://doi.org/10.1111/jrh.12913.
Export RIS Citation Information. TY - Journal Article AU - Vasudevan, Lavanya AU - Wang, Yunfei AU - Ostermann, Jan AU - Yelverton, Valerie AU - Yang, Jingyi AU - Fish, Laura J. AU - Harrison, Sayward E. AU - Williams, Charnetta AU - Walter, Emmanuel B. AB - Rural adolescents in the United States lag behind their urban counterparts in the uptake of the human papillomavirus (HPV) vaccine. However, a systematic assessment of factors associated with rural-urban disparities in HPV vaccination coverage to inform potential vaccination promotion interventions is lacking in the literature. Prioritizing HPV vaccination for rural adolescents is necessary for increasing overall HPV vaccination coverage for adolescents and for reducing the incidence of HPV infections and future HPV-related cancers. AB - We conducted a cross-sectional survey of caregivers of adolescents aged 9-17 years from 13 states located in the southern United States. Participants were recruited from a nationally representative online survey panel and self-administered the survey from December 2019 to January 2020. The survey assessed HPV vaccination initiation and series completion for rural and urban adolescents, and sought to systematically identify modifiable factors (eg, caregiver knowledge and attitudes about HPV/HPV vaccine, health care access) and nonmodifiable factors (eg, sociodemographic characteristics) that may be associated with rural-urban disparities in adolescent HPV vaccination. Rural versus urban residence status of respondents was determined using the US Census definition and Federal Information Processing System (FIPS) codes. AB - Among 2,262 sampled caregivers, data from 987 respondents (43.6%) were included in the analysis; 193 respondents (19.6%) were from rural areas and 794 (80.4%) were from urban areas. Overall, 333 (33.7%) adolescents had received at least 1 dose of HPV vaccination and 259 (26.3%) adolescents had completed HPV vaccination. In comparison to urban adolescents, fewer rural adolescents had initiated (-7.7 percentage points) or completed (-14.9 percentage points) HPV vaccination. Uptake of tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal (MenACWY), and influenza vaccines was similar between urban and rural adolescents. Caregiver attitudes, but not their knowledge about HPV infection or the HPV vaccine, were associated with disparities in HPV vaccination initiation. Rural caregivers were more likely to report concerns with the HPV vaccine, lower access to a pediatric primary care provider, longer travel times to reach health care providers, and HPV vaccination at age 11 years or older compared with age 9 or 10 years. When compared with urban caregivers, fewer rural caregivers reported discussing HPV vaccination with their adolescent's provider although difference in the receipt of a provider recommendation was not statistically significant between rural and urban adolescents. AB - Our findings confirm rural-urban disparities in HPV vaccination coverage for adolescents living in the 13 southern US states. Future research efforts to reduce rural-urban disparities in HPV vaccination should evaluate the impacts of interventions that increase positive caregiver attitudes about HPV vaccination, expand access to vaccination services and pediatricians for rural adolescents, enable strong provider recommendations, and increase the window of HPV vaccination by promoting vaccination initiation at younger ages (9-10 years). While this analysis focused on rural-urban disparities, lower rates of HPV vaccination overall suggest that interventions in rural areas be implemented alongside broader efforts to promote adolescent HPV vaccination coverage in the southern United States. AB - Author manuscript AN - cdc:261498 C4 - PMC12168015 DO - https://doi.org/10.1111/jrh.12913 IS - 2 J2 - The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association KW - Adolescent KW - Female KW - Vaccination KW - Papillomavirus Vaccines KW - Child KW - Cross-Sectional Studies KW - Papillomavirus Infections KW - Surveys and Questionnaires KW - Healthcare Disparities KW - Urban Population KW - Male KW - Humans KW - Middle Aged KW - Human Papillomavirus Viruses KW - Adult KW - Rural Population KW - adolescents KW - health disparity KW - human papillomavirus KW - rural health KW - Southern United States KW - vaccination KW - Humans KW - Cross-Sectional Studies KW - Female KW - Adolescent KW - Papillomavirus Vaccines KW - Rural Population KW - Male KW - Urban Population KW - Child KW - Surveys and Questionnaires KW - Healthcare Disparities KW - Papillomavirus Infections KW - Vaccination KW - Adult KW - Middle Aged KW - Human Papillomavirus Viruses LA - eng PY - 2025 T2 - The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association T2 - The Journal of Rural Health: Official Journal of the American Rural Health Association and the National Rural Health Care Association, 2025, v. 41, no. 2 TI - Rural-urban Disparities in Human Papillomavirus Vaccination: Findings From a Cross-sectional Survey of 13 Southern US States, December 2019-January 2020. VL - 41 UR - https://stacks.cdc.gov/view/cdc/261498 ER -
Mitigation of Injury From Myocardial Infarction by Pentamidine, an Inhibitor of the Acetyltransferase Tip60.

Wang, Xinrui ;

Harty, Katherine R.

February 2026 | Cardiovascular Drugs and Therapy, 2026, v. 40, no. 1

There is an urgent unmet need for new pharmacologic approaches that promote re-muscularization and repair following myocardial infarction (MI). We previously reported that genetic depletion of the acetyltransferase Tip60 after MI in a mouse model activates the CM cell-cycle, reduces scarring, and restores cardiac function, and that these beneficial ...

10/09/2026

Supporting Files

Title : Mitigation of Injury From Myocardial Infarction by Pentamidine, an Inhibitor of the Acetyltransferase Tip60. Personal Author(s) : Wang, Xinrui;Harty, Katherine R.;Wan, Tina C.;Qu, Zhuocheng;Smith, Brian C.;Lough, John W.;Auchampach, John A.; Published Date : February 2026 Pages in Document : 141-154 (22 pdf pages) Source : Cardiovascular Drugs and Therapy, 2026, v. 40, no. 1 DOI : https://doi.org/10.1007/s10557-025-07696-z Journal Title : Cardiovascular Drugs and Therapy
Wang, X., Harty, K. R., Wan, T. C., Qu, Z., Smith, B. C., Lough, J. W., & Auchampach, J. A. (2026). Mitigation of Injury From Myocardial Infarction by Pentamidine, an Inhibitor of the Acetyltransferase Tip60. Cardiovascular Drugs and Therapy, 40(1). https://doi.org/10.1007/s10557-025-07696-z

Wang, Xinrui, Katherine R. Harty, Tina C. Wan, Zhuocheng Qu, Brian C. Smith, John W. Lough, and John A. Auchampach. "Mitigation of Injury From Myocardial Infarction by Pentamidine, an Inhibitor of the Acetyltransferase Tip60." Cardiovascular Drugs and Therapy 40, no. 1 (2026). https://doi.org/10.1007/s10557-025-07696-z.

Wang, Xinrui, et al. "Mitigation of Injury From Myocardial Infarction by Pentamidine, an Inhibitor of the Acetyltransferase Tip60." Cardiovascular Drugs and Therapy, vol. 40, no. 1, 2026. Stacks. https://doi.org/10.1007/s10557-025-07696-z.
Export RIS Citation Information. TY - Journal Article AU - Wang, Xinrui AU - Harty, Katherine R. AU - Wan, Tina C. AU - Qu, Zhuocheng AU - Smith, Brian C. AU - Lough, John W. AU - Auchampach, John A. AB - There is an urgent unmet need for new pharmacologic approaches that promote re-muscularization and repair following myocardial infarction (MI). We previously reported that genetic depletion of the acetyltransferase Tip60 after MI in a mouse model activates the CM cell-cycle, reduces scarring, and restores cardiac function, and that these beneficial effects are mimicked by the Tip60-selective inhibitor TH1834. Here, we investigated whether the FDA-approved anti-microbial agent pentamidine, a Tip60 inhibitor from which TH1834 is derived, also protects from the damaging effects of MI. AB - Adult (10-14 weeks old) C57Bl/6 mice were subjected to permanent left coronary artery ligation to induce MI. Subsequently, echocardiography, electrocardiography, cardiac staining, and molecular analyses were performed to monitor the effects of treatment with pentamidine on cardiac injury and function. AB - We report that transient systemic administration of pentamidine on days 3-16 post-MI at a daily dose of 3 mg/kg efficiently improved cardiac function for up to ten months. This was accompanied by improved survival, diminished scarring, and increased activation of cell-cycle markers in CMs located in the infarct border zone in the absence of hypertrophy. Histological assessments suggested that post-MI treatment with pentamidine reduced site-specific acetylation of the minor histone variant H2A.Z at lysines K4 and K7 in CMs, indicative of the dedifferentiation process which must occur prior to CM proliferation. Treating mice with pentamidine post-MI produced no prominent electrophysiological changes. AB - These findings support the translational potential of pentamidine for treatment of MI, and provide evidence that functional improvement is mediated, in part, by CM renewal due to inhibition of the acetyltransferase activity of Tip60. AB - Author manuscript AN - cdc:261497 C4 - PMC12641756 DO - https://doi.org/10.1007/s10557-025-07696-z IS - 1 J2 - Cardiovascular Drugs and Therapy KW - Animals KW - Ventricular Remodeling KW - Lysine Acetyltransferase 5 KW - Myocardial Infarction KW - Enzyme Inhibitors KW - Mice, Inbred C57BL KW - Male KW - Ventricular Function, Left KW - Pentamidine KW - Myocytes, Cardiac KW - Disease Models, Animal KW - Mice KW - Pentamidine KW - Myocardial Infarction KW - Cardiomyocyte Dedifferentiation KW - Cell-Cycle Activation KW - Regeneration KW - Tip60 KW - Animals KW - Myocardial Infarction KW - Mice, Inbred C57BL KW - Pentamidine KW - Disease Models, Animal KW - Lysine Acetyltransferase 5 KW - Myocytes, Cardiac KW - Mice KW - Male KW - Ventricular Function, Left KW - Ventricular Remodeling KW - Enzyme Inhibitors LA - eng PY - 2026 T2 - Cardiovascular Drugs and Therapy T2 - Cardiovascular Drugs and Therapy, 2026, v. 40, no. 1 TI - Mitigation of Injury From Myocardial Infarction by Pentamidine, an Inhibitor of the Acetyltransferase Tip60. VL - 40 UR - https://stacks.cdc.gov/view/cdc/261497 ER -
Occupational Health Equity: a Call to Consider Social-structural Factors in Injury Prevention Research.

Guillot-Wright, Shannon ;

McClure, Elizabeth S

September 2025 | Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, 2025, v. 31, no. 5

Occupational health equity scholarship has been growing over the past decade, including social-structural determinants of health research that centres the voices and experiences of historically marginalised communities. In our commentary, we focus on the intersection of work-related and non-work-related factors and how they impact the health of wor ...

10/09/2026

Supporting Files

Title : Occupational Health Equity: a Call to Consider Social-structural Factors in Injury Prevention Research. Personal Author(s) : Guillot-Wright, Shannon;McClure, Elizabeth S;Ramirez, Marizen R;Trotter, Alexis Grimes;Richardson, David B; Published Date : September 2025 Pages in Document : 354-356 (6 pdf pages) Source : Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, 2025, v. 31, no. 5 DOI : https://doi.org/10.1136/ip-2024-045603 Journal Title : Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention
Guillot-Wright, S., McClure, E. S., Ramirez, M. R., Trotter, A. G., & Richardson, D. B. (2025). Occupational Health Equity: a Call to Consider Social-structural Factors in Injury Prevention Research. Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, 31(5). https://doi.org/10.1136/ip-2024-045603

Guillot-Wright, Shannon, Elizabeth S McClure, Marizen R Ramirez, Alexis Grimes Trotter, and David B Richardson. "Occupational Health Equity: a Call to Consider Social-structural Factors in Injury Prevention Research." Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention 31, no. 5 (2025). https://doi.org/10.1136/ip-2024-045603.

Guillot-Wright, Shannon, et al. "Occupational Health Equity: a Call to Consider Social-structural Factors in Injury Prevention Research." Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, vol. 31, no. 5, 2025. Stacks. https://doi.org/10.1136/ip-2024-045603.
Export RIS Citation Information. TY - Journal Article AU - Guillot-Wright, Shannon AU - McClure, Elizabeth S AU - Ramirez, Marizen R AU - Trotter, Alexis Grimes AU - Richardson, David B AB - Occupational health equity scholarship has been growing over the past decade, including social-structural determinants of health research that centres the voices and experiences of historically marginalised communities. In our commentary, we focus on the intersection of work-related and non-work-related factors and how they impact the health of workers, their families and their communities through community-engaged research. Case studies include the implementation of mobile clinics that are developed alongside communities, community organising to examine and reduce health disparities among racially segregated workers, the development of research instruments and measures to study racism and discrimination, and a focus on how the distribution of employment opportunity is an important point of intervention to eliminate injury disparities. AB - Author manuscript AN - cdc:261496 C4 - PMC12335749 DO - https://doi.org/10.1136/ip-2024-045603 IS - 5 J2 - Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention KW - Community-Based Participatory Research KW - Health Equity KW - Health Status Disparities KW - Social Determinants of Health KW - Humans KW - Occupational Injuries KW - Occupational Health KW - Racism KW - Humans KW - Health Equity KW - Occupational Health KW - Social Determinants of Health KW - Health Status Disparities KW - Occupational Injuries KW - Community-Based Participatory Research KW - Racism LA - eng PY - 2025 T2 - Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention T2 - Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, 2025, v. 31, no. 5 TI - Occupational Health Equity: a Call to Consider Social-structural Factors in Injury Prevention Research. VL - 31 UR - https://stacks.cdc.gov/view/cdc/261496 ER -
Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People With HIV in Project CoRECT: a Mixed Methods Study.

Macharaviani, Eteri ;

Altice, Frederick L.

August 2025 | AIDS and Behavior, 2025, v. 29, no. 8

The HIV care continuum is a framework that describes gaps in care engagement for people with HIV (PWH) who know their HIV status, are on antiretroviral therapy, and are virally suppressed. Despite the United Nations' 95 - 95 - 95 targets, significant gaps remain in the United States, driven by PWH who are not engaged in care. To evaluate a Data-to- ...

10/09/2026

Supporting Files

Title : Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People With HIV in Project CoRECT: a Mixed Methods Study. Personal Author(s) : Macharaviani, Eteri;Altice, Frederick L.;Shrestha, Roman;Truebig, Janet;Carroll, Constance;Nichols, Lisa;Ahmad, Bachar;Copenhaver, Michael;Villanueva, Merceditas; Published Date : August 2025 Pages in Document : 2451-2460 (16 pdf pages) Source : AIDS and Behavior, 2025, v. 29, no. 8 DOI : https://doi.org/10.1007/s10461-025-04707-w Journal Title : AIDS and Behavior
Macharaviani, E., Altice, F. L., Shrestha, R., Truebig, J., Carroll, C., Nichols, L., Ahmad, B., Copenhaver, M., & Villanueva, M. (2025). Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People With HIV in Project CoRECT: a Mixed Methods Study. AIDS and Behavior, 29(8). https://doi.org/10.1007/s10461-025-04707-w

Macharaviani, Eteri, Frederick L. Altice, Roman Shrestha, Janet Truebig, Constance Carroll, Lisa Nichols, Bachar Ahmad, Michael Copenhaver, and Merceditas Villanueva. "Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People With HIV in Project CoRECT: a Mixed Methods Study." AIDS and Behavior 29, no. 8 (2025). https://doi.org/10.1007/s10461-025-04707-w.

Macharaviani, Eteri, et al. "Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People With HIV in Project CoRECT: a Mixed Methods Study." AIDS and Behavior, vol. 29, no. 8, 2025. Stacks. https://doi.org/10.1007/s10461-025-04707-w.
Export RIS Citation Information. TY - Journal Article AU - Macharaviani, Eteri AU - Altice, Frederick L. AU - Shrestha, Roman AU - Truebig, Janet AU - Carroll, Constance AU - Nichols, Lisa AU - Ahmad, Bachar AU - Copenhaver, Michael AU - Villanueva, Merceditas AB - The HIV care continuum is a framework that describes gaps in care engagement for people with HIV (PWH) who know their HIV status, are on antiretroviral therapy, and are virally suppressed. Despite the United Nations' 95 - 95 - 95 targets, significant gaps remain in the United States, driven by PWH who are not engaged in care. To evaluate a Data-to-Care strategy to re-engage PWH who recently fell out of care, the Centers for Disease Control and Prevention funded a randomized, controlled trial called the Cooperative Re-Engagement Controlled Trial (CoRECT) was conducted in Connecticut, Massachusetts, and Pennsylvania between 2014 and 2018. Three Disease Intervention Specialists (DIS) were trained to provide a public health intervention that adapted the Anti-Retroviral Treatment and Access to Services (ARTAS) model for re-engaging PWH in care. In this secondary analysis, we examined the implementation processes and field experiences of DIS in Connecticut using an explanatory sequential mixed methods design. Data sources included DIS field notes, an internal database, and in-depth interviews with two DIS. We found that the fidelity to the adapted ARTAS (ARTAS+) varied considerably, barriers to care assessments were completed consistently (95%), and structured interactive sessions were completed less frequently (35%). Qualitative interviews with DIS highlighted the importance of flexibility and rapport-building in re-engagement efforts. Re-engagement efforts were negatively impacted by psychiatric and substance use disorders and homelessness, while patient-reported barriers included time mismanagement, inconvenient clinic operational hours, or not perceiving themselves as sick. The study provides a roadmap for future Data-to-Care implementation efforts and underscores the importance of patient-centered approaches for re-engaging PWH in care. TRIAL REGISTRATION: https://www.clinicaltrials.gov/ with an identifier NCT02693145. AB - Author manuscript AN - cdc:261495 C4 - PMC12353047 DO - https://doi.org/10.1007/s10461-025-04707-w IS - 8 J2 - AIDS and Behavior KW - Continuity of Patient Care KW - Female KW - Qualitative Research KW - Male KW - Middle Aged KW - Humans KW - Health Services Accessibility KW - Adult KW - HIV Infections KW - Data-to-care KW - HIV KW - implementation science KW - HIV treatment as prevention KW - disease intervention specialists KW - Humans KW - HIV Infections KW - Male KW - Female KW - Continuity of Patient Care KW - Health Services Accessibility KW - Adult KW - Middle Aged KW - Qualitative Research LA - eng PY - 2025 T2 - AIDS and Behavior T2 - AIDS and Behavior, 2025, v. 29, no. 8 TI - Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People With HIV in Project CoRECT: a Mixed Methods Study. VL - 29 UR - https://stacks.cdc.gov/view/cdc/261495 ER -
Associations Between U.S. High-School Student and Parental Job Loss During the COVID-19 Pandemic and Student Substance Use: Adolescent Behaviors and Experiences Survey (ABES), 2021.

Shockey, Taylor M. ;

Silver, Sharon R.

August 19, 2025 | Substance Use & Misuse, 2025, v. 60, no. 8

Job loss among both adults and adolescents increased markedly early in the COVID-19 pandemic. While parental job loss has been associated with the adverse effects, including adolescent substance use, no research is available on the effects of adolescent job loss on substance use.Analyses of Adolescent Behaviors and Experiences Survey (ABES) data fr ...

10/09/2026

Supporting Files

Title : Associations Between U.S. High-School Student and Parental Job Loss During the COVID-19 Pandemic and Student Substance Use: Adolescent Behaviors and Experiences Survey (ABES), 2021. Personal Author(s) : Shockey, Taylor M.;Silver, Sharon R.; Published Date : August 19, 2025 Pages in Document : 1089-1098 (19 pdf pages) Source : Substance Use & Misuse, 2025, v. 60, no. 8 DOI : https://doi.org/10.1080/10826084.2025.2481318 Journal Title : Substance Use & Misuse
Shockey, T. M., & Silver, S. R. (2025). Associations Between U.S. High-School Student and Parental Job Loss During the COVID-19 Pandemic and Student Substance Use: Adolescent Behaviors and Experiences Survey (ABES), 2021. Substance Use & Misuse, 60(8). https://doi.org/10.1080/10826084.2025.2481318

Shockey, Taylor M. and Sharon R. Silver. "Associations Between U.S. High-School Student and Parental Job Loss During the COVID-19 Pandemic and Student Substance Use: Adolescent Behaviors and Experiences Survey (ABES), 2021." Substance Use & Misuse 60, no. 8 (2025). https://doi.org/10.1080/10826084.2025.2481318.

Shockey, Taylor M., and Sharon R. Silver "Associations Between U.S. High-School Student and Parental Job Loss During the COVID-19 Pandemic and Student Substance Use: Adolescent Behaviors and Experiences Survey (ABES), 2021." Substance Use & Misuse, vol. 60, no. 8, 2025. Stacks. https://doi.org/10.1080/10826084.2025.2481318.
Export RIS Citation Information. TY - Journal Article AU - Shockey, Taylor M. AU - Silver, Sharon R. AB - Job loss among both adults and adolescents increased markedly early in the COVID-19 pandemic. While parental job loss has been associated with the adverse effects, including adolescent substance use, no research is available on the effects of adolescent job loss on substance use. AB - Analyses of Adolescent Behaviors and Experiences Survey (ABES) data from January to June 2021 were conducted to assess associations between parent and student pre-pandemic employment status and pandemic-era job loss and adolescent substance use behaviors. Cigarette, electronic vapor product (EVP), alcohol, and drug use were examined in a nationally representative sample of 7,705 U.S. high-school students. AB - Compared to students who did not lose their job during the pandemic, students reporting job loss had significantly elevated prevalences of current EVP use (29.9% vs. 19.7%), drinking more alcohol during the pandemic (25.3% vs. 16.7%), and current marijuana use (25.8% vs. 15.6%). Additionally, parental job loss was significantly associated with all substance use behaviors. AB - Higher levels of substance use associated with student and parental job loss, as well as parental unemployment, indicate that care may be needed for those students experiencing these losses. School-based intervention and prevention programs, including job loss supports for students, could be useful. AB - Author manuscript AN - cdc:261494 C4 - PMC12362230 DO - https://doi.org/10.1080/10826084.2025.2481318 IS - 8 J2 - Substance Use & Misuse KW - Adolescent KW - Female KW - Alcohol Drinking KW - Parents KW - SARS-CoV-2 KW - COVID-19 KW - Unemployment KW - Surveys and Questionnaires KW - Students KW - Male KW - Humans KW - Substance-Related Disorders KW - Adolescent Behavior KW - Employment status KW - job loss KW - COVID-19 pandemic KW - adolescent health KW - tobacco and electronic vapor product (EVP) use KW - alcohol use KW - drug use KW - Humans KW - COVID-19 KW - Adolescent KW - Male KW - Female KW - Students KW - Unemployment KW - Substance-Related Disorders KW - Adolescent Behavior KW - Parents KW - Surveys and Questionnaires KW - Alcohol Drinking KW - SARS-CoV-2 LA - eng PY - 2025 T2 - Substance Use & Misuse T2 - Substance Use & Misuse, 2025, v. 60, no. 8 TI - Associations Between U.S. High-School Student and Parental Job Loss During the COVID-19 Pandemic and Student Substance Use: Adolescent Behaviors and Experiences Survey (ABES), 2021. VL - 60 UR - https://stacks.cdc.gov/view/cdc/261494 ER -
Projecting Maximum Potential Demand For Nirsevimab to Protect Eligible US Infants and Young Children Against Respiratory Syncytial Virus in the 2024/2025 Season.

Olesen, Scott W. ;

Holmdahl, Inga

April 2025 | Vaccine, 2025, v. 53

Nirsevimab is a long-acting monoclonal antibody that protects infants and young children against severe respiratory syncytial virus (RSV) disease. Children are eligible for one 50 mg dose, one 100 mg dose, or two 100 mg doses of nirsevimab based on age, weight, time of year, maternal vaccination, and risk of severe disease. In winter 2023/2024, we ...

10/09/2026

Supporting Files

Title : Projecting Maximum Potential Demand For Nirsevimab to Protect Eligible US Infants and Young Children Against Respiratory Syncytial Virus in the 2024/2025 Season. Personal Author(s) : Olesen, Scott W.;Holmdahl, Inga;Ortega-Sanchez, Ismael R.;Biggerstaff, Matthew;Jones, Jefferson M.;McMorrow, Meredith L.;Fleming-Dutra, Katherine E.; Published Date : April 2025 Pages in Document : 127109 (12 pdf pages) Source : Vaccine, 2025, v. 53 DOI : https://doi.org/10.1016/j.vaccine.2025.127109 Journal Title : Vaccine
Olesen, S. W., Holmdahl, I., Ortega-Sanchez, I. R., Biggerstaff, M., Jones, J. M., McMorrow, M. L., & Fleming-Dutra, K. E. (2025). Projecting Maximum Potential Demand For Nirsevimab to Protect Eligible US Infants and Young Children Against Respiratory Syncytial Virus in the 2024/2025 Season. Vaccine, 53. https://doi.org/10.1016/j.vaccine.2025.127109

Olesen, Scott W., Inga Holmdahl, Ismael R. Ortega-Sanchez, Matthew Biggerstaff, Jefferson M. Jones, Meredith L. McMorrow, and Katherine E. Fleming-Dutra. "Projecting Maximum Potential Demand For Nirsevimab to Protect Eligible US Infants and Young Children Against Respiratory Syncytial Virus in the 2024/2025 Season." Vaccine 53 (2025). https://doi.org/10.1016/j.vaccine.2025.127109.

Olesen, Scott W., et al. "Projecting Maximum Potential Demand For Nirsevimab to Protect Eligible US Infants and Young Children Against Respiratory Syncytial Virus in the 2024/2025 Season." Vaccine, vol. 53, 2025. Stacks. https://doi.org/10.1016/j.vaccine.2025.127109.
Export RIS Citation Information. TY - Journal Article AU - Olesen, Scott W. AU - Holmdahl, Inga AU - Ortega-Sanchez, Ismael R. AU - Biggerstaff, Matthew AU - Jones, Jefferson M. AU - McMorrow, Meredith L. AU - Fleming-Dutra, Katherine E. AB - Nirsevimab is a long-acting monoclonal antibody that protects infants and young children against severe respiratory syncytial virus (RSV) disease. Children are eligible for one 50 mg dose, one 100 mg dose, or two 100 mg doses of nirsevimab based on age, weight, time of year, maternal vaccination, and risk of severe disease. In winter 2023/2024, we developed a model to project the number of nirsevimab doses needed to immunize all eligible U.S. children during the 2024/2025 season. We grouped all births from March 2023 through March 2025 into weekly cohorts, partitioned those cohorts based on eligibility criteria, and computed eligibility for each partition. In the absence of maternal RSV vaccination, we estimated U.S. children would be eligible to receive 4.3 million nirsevimab doses in 2024/2025, of which 48% would be 100 mg doses. Projections of total eligibility can be used to inform production goals and avoid shortages of nirsevimab. AB - Author manuscript AN - cdc:261493 C4 - PMC12014342 DO - https://doi.org/10.1016/j.vaccine.2025.127109 J2 - Vaccine KW - Antiviral Agents KW - Female KW - Vaccination KW - Infant KW - Seasons KW - Respiratory Syncytial Virus Infections KW - Male KW - Humans KW - Child, Preschool KW - Infant, Newborn KW - Antibodies, Monoclonal, Humanized KW - Respiratory Syncytial Virus, Human KW - Respiratory syncytial virus KW - Infants and young children KW - Nirsevimab demand KW - Humans KW - Respiratory Syncytial Virus Infections KW - Infant KW - Antibodies, Monoclonal, Humanized KW - Child, Preschool KW - Female KW - Respiratory Syncytial Virus, Human KW - Antiviral Agents KW - Seasons KW - Infant, Newborn KW - Male KW - Vaccination LA - eng PY - 2025 T2 - Vaccine T2 - Vaccine, 2025, v. 53 TI - Projecting Maximum Potential Demand For Nirsevimab to Protect Eligible US Infants and Young Children Against Respiratory Syncytial Virus in the 2024/2025 Season. VL - 53 UR - https://stacks.cdc.gov/view/cdc/261493 ER -
Exploring Relationships Among Smoking Cessation App Use, Smoking Behavioral Outcomes, and Pharmacotherapy Utilization Among Individuals Who Smoke Cigarettes.

Lawson, Schuyler C. ;

Kasza, Karin

August 2025 | Addictive Behaviors, 2025, v. 167

Most individuals who smoke cigarettes are interested in quitting, but many are unable to quit. Fewer than one-third of individuals who smoke cigarettes attempt to quit using FDA-approved cessation methods, such as nicotine replacement therapy (NRT) and prescription medications. Smoking cessation apps (SCAs) provide individuals with personalized qui ...

10/09/2026

Supporting Files

Title : Exploring Relationships Among Smoking Cessation App Use, Smoking Behavioral Outcomes, and Pharmacotherapy Utilization Among Individuals Who Smoke Cigarettes. Personal Author(s) : Lawson, Schuyler C.;Kasza, Karin;Collins, R.Lorraine;O'Connor, Richard J.;Homish, Gregory G.; Published Date : August 2025 Pages in Document : 108354 (22 pdf pages) Source : Addictive Behaviors, 2025, v. 167 DOI : https://doi.org/10.1016/j.addbeh.2025.108354 Journal Title : Addictive Behaviors
Lawson, S. C., Kasza, K., Collins, R., O'Connor, R. J., & Homish, G. G. (2025). Exploring Relationships Among Smoking Cessation App Use, Smoking Behavioral Outcomes, and Pharmacotherapy Utilization Among Individuals Who Smoke Cigarettes. Addictive Behaviors, 167. https://doi.org/10.1016/j.addbeh.2025.108354

Lawson, Schuyler C., Karin Kasza, R.Lorraine Collins, Richard J. O'Connor, and Gregory G. Homish. "Exploring Relationships Among Smoking Cessation App Use, Smoking Behavioral Outcomes, and Pharmacotherapy Utilization Among Individuals Who Smoke Cigarettes." Addictive Behaviors 167 (2025). https://doi.org/10.1016/j.addbeh.2025.108354.

Lawson, Schuyler C., et al. "Exploring Relationships Among Smoking Cessation App Use, Smoking Behavioral Outcomes, and Pharmacotherapy Utilization Among Individuals Who Smoke Cigarettes." Addictive Behaviors, vol. 167, 2025. Stacks. https://doi.org/10.1016/j.addbeh.2025.108354.
Export RIS Citation Information. TY - Journal Article AU - Lawson, Schuyler C. AU - Kasza, Karin AU - Collins, R.Lorraine AU - O'Connor, Richard J. AU - Homish, Gregory G. AB - Most individuals who smoke cigarettes are interested in quitting, but many are unable to quit. Fewer than one-third of individuals who smoke cigarettes attempt to quit using FDA-approved cessation methods, such as nicotine replacement therapy (NRT) and prescription medications. Smoking cessation apps (SCAs) provide individuals with personalized quit plans, information about smoking cessation treatments, craving management strategies, and other features. However, their relationship to NRT/prescription medication utilization and quit attempts is understudied. AB - We conducted a longitudinal secondary data analysis using a subset of adults who smoked at least 100 cigarettes in their lifetime, currently smoked every day or some days, and planned to quit within a year. This subset was drawn from the Population Assessment of Tobacco and Health (PATH) Study, a nationally representative cohort study. We utilized Generalizing Estimating Equation models to examine the longitudinal associations between SCA use initiation and the following outcomes across 2014-2019: NRT, prescription medications, and quit attempts. AB - SCA use initiation was associated with greater odds of prescription medication utilization (AOR = 2.43, 95 % CI: 1.63, 3.64; p < 0.05). Likewise, SCA use initiation was associated with greater odds of making a quit attempt (AOR = 1.38, 95 % CI: 1.09, 1.76; p < 0.01), but not NRT utilization. AB - Among adults who regularly smoked cigarettes and had plans to quit, SCA use initiation was associated with prescription medication utilization and quit attempts but not NRT utilization. SCAs may have utility as a population-level intervention but specific features needed to be studied further. AB - SCA, Smoking Cessation App; NRT, Nicotine Replacement Therapy. AB - Author manuscript AN - cdc:261492 C4 - PMC12128583 DO - https://doi.org/10.1016/j.addbeh.2025.108354 J2 - Addictive Behaviors KW - Longitudinal Studies KW - Smoking Cessation KW - Female KW - Tobacco Use Cessation Devices KW - Mobile Applications KW - Male KW - Humans KW - Middle Aged KW - Smoking Cessation Agents KW - Young Adult KW - Adult KW - Cigarette Smoking KW - Smoking cessation apps KW - NRT KW - Prescription medications KW - PATH KW - Longitudinal KW - Humans KW - Smoking Cessation KW - Male KW - Female KW - Adult KW - Tobacco Use Cessation Devices KW - Mobile Applications KW - Middle Aged KW - Longitudinal Studies KW - Smoking Cessation Agents KW - Cigarette Smoking KW - Young Adult LA - eng PY - 2025 T2 - Addictive Behaviors T2 - Addictive Behaviors, 2025, v. 167 TI - Exploring Relationships Among Smoking Cessation App Use, Smoking Behavioral Outcomes, and Pharmacotherapy Utilization Among Individuals Who Smoke Cigarettes. VL - 167 UR - https://stacks.cdc.gov/view/cdc/261492 ER -
Health Conditions in Wyoming Miners as Reflected in Wyoming Miner's Hospital Insurance Claims, 2014-2023.

Yeoman, Kristin ;

Chin, Brian

August 2025 | Journal of Occupational and Environmental Medicine, 2025, v. 67, no. 8

This study examines the prevalence of health conditions for which miners enrolled in a state-funded insurance program sought care.We conducted a retrospective analysis of claims data submitted to the Wyoming Miner's Hospital during 2014-2023. Using International Classification of Diseases codes and identifiers unique to each miner, we calculated th ...

10/09/2026

Supporting Files

Title : Health Conditions in Wyoming Miners as Reflected in Wyoming Miner's Hospital Insurance Claims, 2014-2023. Personal Author(s) : Yeoman, Kristin;Chin, Brian;Krieg, Edward;Robinson, Tashina;Poplin, Gerald; Published Date : August 2025 Pages in Document : e562-e567 (17 pdf pages) Source : Journal of Occupational and Environmental Medicine, 2025, v. 67, no. 8 DOI : https://doi.org/10.1097/JOM.0000000000003411 Journal Title : Journal of Occupational and Environmental Medicine
Yeoman, K., Chin, B., Krieg, E., Robinson, T., & Poplin, G. (2025). Health Conditions in Wyoming Miners as Reflected in Wyoming Miner's Hospital Insurance Claims, 2014-2023. Journal of Occupational and Environmental Medicine, 67(8). https://doi.org/10.1097/JOM.0000000000003411

Yeoman, Kristin, Brian Chin, Edward Krieg, Tashina Robinson, and Gerald Poplin. "Health Conditions in Wyoming Miners as Reflected in Wyoming Miner's Hospital Insurance Claims, 2014-2023." Journal of Occupational and Environmental Medicine 67, no. 8 (2025). https://doi.org/10.1097/JOM.0000000000003411.

Yeoman, Kristin, et al. "Health Conditions in Wyoming Miners as Reflected in Wyoming Miner's Hospital Insurance Claims, 2014-2023." Journal of Occupational and Environmental Medicine, vol. 67, no. 8, 2025. Stacks. https://doi.org/10.1097/JOM.0000000000003411.
Export RIS Citation Information. TY - Journal Article AU - Yeoman, Kristin AU - Chin, Brian AU - Krieg, Edward AU - Robinson, Tashina AU - Poplin, Gerald AB - This study examines the prevalence of health conditions for which miners enrolled in a state-funded insurance program sought care. AB - We conducted a retrospective analysis of claims data submitted to the Wyoming Miner's Hospital during 2014-2023. Using International Classification of Diseases codes and identifiers unique to each miner, we calculated the number of unique miners with claims submitted for major disease categories and common diagnoses within each category. AB - Musculoskeletal disorders (MSDs) and diseases of the endocrine and cardiovascular systems were the most prevalent conditions, affecting 72.7%, 34.2%, and 31.1% of enrolled miners, respectively. AB - This population of miners has a substantial burden of health conditions that can adversely impact health and well-being. Mine safety and health professionals can use analyses of claims data to identify priorities for improving miner health and well-being. AB - Author manuscript AN - cdc:261491 C4 - PMC13120154 DO - https://doi.org/10.1097/JOM.0000000000003411 IS - 8 J2 - Journal of Occupational and Environmental Medicine KW - Cardiovascular Diseases KW - Female KW - Insurance Claim Review KW - Musculoskeletal Diseases KW - Young Adult KW - Mining KW - Retrospective Studies KW - Occupational Diseases KW - Prevalence KW - Male KW - Miners KW - Middle Aged KW - Humans KW - Adult KW - Miners KW - health conditions KW - musculoskeletal disorders KW - well-being KW - Humans KW - Retrospective Studies KW - Adult KW - Occupational Diseases KW - Male KW - Middle Aged KW - Musculoskeletal Diseases KW - Female KW - Insurance Claim Review KW - Mining KW - Prevalence KW - Cardiovascular Diseases KW - Miners KW - Young Adult LA - eng PY - 2025 T2 - Journal of Occupational and Environmental Medicine T2 - Journal of Occupational and Environmental Medicine, 2025, v. 67, no. 8 TI - Health Conditions in Wyoming Miners as Reflected in Wyoming Miner's Hospital Insurance Claims, 2014-2023. VL - 67 UR - https://stacks.cdc.gov/view/cdc/261491 ER -
Foot-body Coupling Angle is a Strong Kinematic Predictor of Friction Requirements During Ladder Descent: Implications For Slipping Risk.

Griffin, Sarah C. ;

Williams, Violet M.

May 2025 | Journal of Biomechanics, 2025, v. 184

Slips and falls from ladders are a common cause of workplace injuries, yet insufficient research explains the cause of these incidents. This study identifies the association between the required coefficient of friction (RCOF) and biomechanical factors (foot angle, body angle, foot-body coupling angle, foot contact velocity, foot placement, and trun ...

10/09/2026

Supporting Files

Title : Foot-body Coupling Angle is a Strong Kinematic Predictor of Friction Requirements During Ladder Descent: Implications For Slipping Risk. Personal Author(s) : Griffin, Sarah C.;Williams, Violet M.;Redfern, Mark S.;Beschorner, Kurt E.; Published Date : May 2025 Pages in Document : 112661 (15 pdf pages) Source : Journal of Biomechanics, 2025, v. 184 DOI : https://doi.org/10.1016/j.jbiomech.2025.112661 Journal Title : Journal of Biomechanics
Griffin, S. C., Williams, V. M., Redfern, M. S., & Beschorner, K. E. (2025). Foot-body Coupling Angle is a Strong Kinematic Predictor of Friction Requirements During Ladder Descent: Implications For Slipping Risk. Journal of Biomechanics, 184. https://doi.org/10.1016/j.jbiomech.2025.112661

Griffin, Sarah C., Violet M. Williams, Mark S. Redfern, and Kurt E. Beschorner. "Foot-body Coupling Angle is a Strong Kinematic Predictor of Friction Requirements During Ladder Descent: Implications For Slipping Risk." Journal of Biomechanics 184 (2025). https://doi.org/10.1016/j.jbiomech.2025.112661.

Griffin, Sarah C., et al. "Foot-body Coupling Angle is a Strong Kinematic Predictor of Friction Requirements During Ladder Descent: Implications For Slipping Risk." Journal of Biomechanics, vol. 184, 2025. Stacks. https://doi.org/10.1016/j.jbiomech.2025.112661.
Export RIS Citation Information. TY - Journal Article AU - Griffin, Sarah C. AU - Williams, Violet M. AU - Redfern, Mark S. AU - Beschorner, Kurt E. AB - Slips and falls from ladders are a common cause of workplace injuries, yet insufficient research explains the cause of these incidents. This study identifies the association between the required coefficient of friction (RCOF) and biomechanical factors (foot angle, body angle, foot-body coupling angle, foot contact velocity, foot placement, and trunk center of mass velocity) during ladder descent. In bivariate regression analyses with the ladder angle as a covariate, foot angle was negatively associated with RCOF (i.e. toe-down has a higher RCOF) (t AB - = -19.8, p < 0.001). The body angle was negatively associated with RCOF (i.e. aligning the center of mass above the foot has a higher RCOF) (t AB - = -3.4, p = 0.001) and there was a positive association between the foot contact velocity and the RCOF (t AB - = 5.2, p < 0.001). Additionally, there was a strong association between the foot-body coupling angle and the RCOF (t AB - = 21.8, p < 0.001, R AB - = 0.606) in which the ladder angle had a small effect. A multivariate model supported that both the foot (t AB - = -21.3, p < 0.001) and body angle (t AB - = 8.2, p < 0.001) independently contributed to the RCOF, which supported the validity of the foot-body coupling angle. This work indicates that the foot-body coupling angle is a compelling metric associated with RCOF and could be used to train safer climbing techniques and monitor behavior to reduce ladder slip and fall events. AB - Author manuscript AN - cdc:261490 C4 - PMC13195415 DO - https://doi.org/10.1016/j.jbiomech.2025.112661 J2 - Journal of Biomechanics KW - Female KW - Foot KW - Male KW - Humans KW - Accidental Falls KW - Biomechanical Phenomena KW - Adult KW - Friction KW - Slips, trips, and falls KW - Ladders KW - Climbing KW - Required coefficient of friction KW - Center of mass KW - Humans KW - Friction KW - Foot KW - Biomechanical Phenomena KW - Accidental Falls KW - Male KW - Female KW - Adult LA - eng PY - 2025 T2 - Journal of Biomechanics T2 - Journal of Biomechanics, 2025, v. 184 TI - Foot-body Coupling Angle is a Strong Kinematic Predictor of Friction Requirements During Ladder Descent: Implications For Slipping Risk. VL - 184 UR - https://stacks.cdc.gov/view/cdc/261490 ER -
Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States.

Morris, Sinead E. ;

Mathis, Sarabeth M.

October 2025 | The Journal of Infectious Diseases, 2025, v. 232, no. 4

Seasonal influenza causes an estimated 120 000 to 710 000 hospitalizations annually in the United States. Treatment with antiviral medications, such as oseltamivir, can reduce risks of hospitalization among people with influenza-associated illness. The US Centers for Disease Control and Prevention recommends initiating antiviral treatment as soon a ...

10/09/2026

Supporting Files

Title : Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States. Personal Author(s) : Morris, Sinead E.;Mathis, Sarabeth M.;Reeves, Emily;Chung, Jessie R.;Borchering, Rebecca K.;Lewis, Nathaniel M.;Masalovich, Svetlana;Garg, Shikha;Uyeki, Timothy M.;Iuliano, A. Danielle;Tenforde, Mark W.;Reed, Carrie;Biggerstaff, Matthew; Published Date : October 2025 Pages in Document : 923-932 (17 pdf pages) Source : The Journal of Infectious Diseases, 2025, v. 232, no. 4 DOI : https://doi.org/10.1093/infdis/jiaf061 Journal Title : The Journal of Infectious Diseases
Morris, S. E., Mathis, S. M., Reeves, E., Chung, J. R., Borchering, R. K., Lewis, N. M., Masalovich, S., Garg, S., Uyeki, T. M., Iuliano, A. D., Tenforde, M. W., Reed, C., & Biggerstaff, M. (2025). Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States. The Journal of Infectious Diseases, 232(4). https://doi.org/10.1093/infdis/jiaf061

Morris, Sinead E., Sarabeth M. Mathis, Emily Reeves, Jessie R. Chung, Rebecca K. Borchering, Nathaniel M. Lewis, and Svetlana Masalovich, et al.. "Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States." The Journal of Infectious Diseases 232, no. 4 (2025). https://doi.org/10.1093/infdis/jiaf061.

Morris, Sinead E., et al. "Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States." The Journal of Infectious Diseases, vol. 232, no. 4, 2025. Stacks. https://doi.org/10.1093/infdis/jiaf061.
Export RIS Citation Information. TY - Journal Article AU - Morris, Sinead E. AU - Mathis, Sarabeth M. AU - Reeves, Emily AU - Chung, Jessie R. AU - Borchering, Rebecca K. AU - Lewis, Nathaniel M. AU - Masalovich, Svetlana AU - Garg, Shikha AU - Uyeki, Timothy M. AU - Iuliano, A. Danielle AU - Tenforde, Mark W. AU - Reed, Carrie AU - Biggerstaff, Matthew AB - Seasonal influenza causes an estimated 120 000 to 710 000 hospitalizations annually in the United States. Treatment with antiviral medications, such as oseltamivir, can reduce risks of hospitalization among people with influenza-associated illness. The US Centers for Disease Control and Prevention recommends initiating antiviral treatment as soon as possible for outpatients with suspected or confirmed influenza who have severe or progressive illness or are at higher risk of influenza complications. AB - We developed a probabilistic model to estimate the impact of antiviral treatment in reducing hospitalizations among US outpatients with influenza. Parameters were informed by seasonal influenza surveillance platforms and stratified by age group and whether individuals had a condition associated with higher risk of influenza complications. We modeled different scenarios for influenza antiviral effectiveness and outpatient testing and prescribing practices, then compared our results with a baseline scenario in which antivirals were not used. AB - Across the modeled scenarios, antiviral treatment resulted in 1215 to 14 184 fewer influenza-associated hospitalizations on average when compared with the baseline scenario (0.2%-2.7% reduction). The greatest effects occurred among adults aged ≥65 years and individuals with conditions associated with higher risk of influenza complications. Modeling 50% improvements in access to care, testing, prescribing, and treatment resulted in greater potential impacts, with over 71 000 (13.3%) influenza-associated hospitalizations averted on average compared to baseline. AB - Our results support recommendations to prioritize outpatient antiviral treatment among older adults and others at higher risk of influenza complications. Improving access to prompt testing and treatment among outpatients with suspected influenza could reduce hospitalizations substantially. AB - Author manuscript AN - cdc:261489 C4 - PMC13080727 DO - https://doi.org/10.1093/infdis/jiaf061 IS - 4 J2 - The Journal of Infectious Diseases KW - Outpatients KW - Adolescent KW - Antiviral Agents KW - Female KW - Aged KW - Infant, Newborn KW - Young Adult KW - Models, Statistical KW - Aged, 80 and over KW - Child KW - Ambulatory Care KW - Infant KW - Hospitalization KW - Oseltamivir KW - Male KW - Humans KW - Middle Aged KW - Child, Preschool KW - Adult KW - Influenza, Human KW - influenza KW - antivirals KW - oseltamivir KW - outpatient treatment KW - hospitalization KW - Humans KW - Influenza, Human KW - Antiviral Agents KW - Hospitalization KW - Middle Aged KW - Adult KW - Aged KW - Adolescent KW - Young Adult KW - Child KW - Child, Preschool KW - Infant KW - Male KW - Female KW - Outpatients KW - Models, Statistical KW - Aged, 80 and over KW - Ambulatory Care KW - Oseltamivir KW - Infant, Newborn LA - eng PY - 2025 T2 - The Journal of Infectious Diseases T2 - The Journal of Infectious Diseases, 2025, v. 232, no. 4 TI - Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States. VL - 232 UR - https://stacks.cdc.gov/view/cdc/261489 ER -
Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States.

Swartwood, Nicole A. ;

Haddad, Maryam B.

July 2025 | Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 2025, v. 28, no. 7

To evaluate the cost-effectiveness of testing and treatment for Mycobacterium tuberculosis (Mtb) infection among Asian and Hispanic persons with diagnosed diabetes in the United States.We estimated population size and Mtb infection prevalence for Asian and Hispanic persons aged ≥15 years with diagnosed, nongestational diabetes, by age and US-born s ...

10/09/2026

Supporting Files

Title : Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States. Personal Author(s) : Swartwood, Nicole A.;Haddad, Maryam B.;Marks, Suzanne M.;Asay, Garrett R. Beeler;Horsburgh, Charles R.;Cohen, Ted;Menzies, Nicolas A.; Published Date : July 2025 Pages in Document : 1029-1037 (19 pdf pages) Source : Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 2025, v. 28, no. 7 DOI : https://doi.org/10.1016/j.jval.2025.03.009 Journal Title : Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Swartwood, N. A., Haddad, M. B., Marks, S. M., Asay, G. R. B., Horsburgh, C. R., Cohen, T., & Menzies, N. A. (2025). Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 28(7). https://doi.org/10.1016/j.jval.2025.03.009

Swartwood, Nicole A., Maryam B. Haddad, Suzanne M. Marks, Garrett R. Beeler Asay, Charles R. Horsburgh, Ted Cohen, and Nicolas A. Menzies. "Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States." Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 28, no. 7 (2025). https://doi.org/10.1016/j.jval.2025.03.009.

Swartwood, Nicole A., et al. "Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States." Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 28, no. 7, 2025. Stacks. https://doi.org/10.1016/j.jval.2025.03.009.
Export RIS Citation Information. TY - Journal Article AU - Swartwood, Nicole A. AU - Haddad, Maryam B. AU - Marks, Suzanne M. AU - Asay, Garrett R. Beeler AU - Horsburgh, Charles R. AU - Cohen, Ted AU - Menzies, Nicolas A. AB - To evaluate the cost-effectiveness of testing and treatment for Mycobacterium tuberculosis (Mtb) infection among Asian and Hispanic persons with diagnosed diabetes in the United States. AB - We estimated population size and Mtb infection prevalence for Asian and Hispanic persons aged ≥15 years with diagnosed, nongestational diabetes, by age and US-born status. We assumed a 1-time test for Mtb infection intervention, with positive-testing persons offered treatment. Using a deterministic, transmission-dynamic model of incident tuberculosis (TB) in the United States, we estimated costs, TB cases and deaths averted, and quality-adjusted life years gained under the intervention compared with no intervention. We estimated incremental cost-effectiveness ratios (ICERs), calculated as costs per quality-adjusted life years gained, from a TB health services perspective, including diagnosis and treatment for TB infection and disease. We also assessed health services and societal perspectives. We estimated 95% uncertainty intervals via probabilistic sensitivity analysis. AB - TB cases averted per 100 000 persons tested ranged from 7.5 (95% uncertainty interval: 6.9-8.1) among US-born Hispanic persons to 238.9 (225.2-254.3) among non-US-born Asian persons. TB deaths averted per 100 000 persons tested ranged from 1.3 (1.2-1.4) among US-born Hispanic persons to 53.7 (51.4-56.1) among non-US-born Asian persons. ICERs for US-born Asian and Hispanic populations were $856 671 ($533 506-$1 234 032) and $1 081 646 ($673 142-$1 551 264), respectively. ICERs for non-US-born Asian and Hispanic populations were lower: $66 664 ($41 456-$93 625) and $68 749 ($43 136-$97 044), respectively. ICERs were 2% to 19% higher under a societal perspective. AB - Although the intervention produced health benefits for all populations assessed, health benefits were greater-and ICERs more favorable-for non-US-born Asian and Hispanic populations with diagnosed diabetes. AB - Author manuscript AN - cdc:261488 C4 - PMC12227287 DO - https://doi.org/10.1016/j.jval.2025.03.009 IS - 7 J2 - Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research KW - Adolescent KW - Female KW - Antitubercular Agents KW - Hispanic or Latino KW - Mycobacterium tuberculosis KW - Diabetes Mellitus KW - Aged KW - Tuberculosis KW - Young Adult KW - Asian KW - Quality-Adjusted Life Years KW - Cost-Effectiveness Analysis KW - Prevalence KW - Male KW - Humans KW - Middle Aged KW - Adult KW - Mycobacterium tuberculosis infection KW - mathematical modeling KW - persons with diabetes KW - cost-effectiveness analysis KW - Adolescent KW - Adult KW - Aged KW - Female KW - Humans KW - Male KW - Middle Aged KW - Young Adult KW - Antitubercular Agents KW - Asian KW - Diabetes Mellitus KW - Hispanic or Latino KW - Mycobacterium tuberculosis KW - Prevalence KW - Quality-Adjusted Life Years KW - Tuberculosis KW - Cost-Effectiveness Analysis LA - eng PY - 2025 T2 - Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research T2 - Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 2025, v. 28, no. 7 TI - Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States. VL - 28 UR - https://stacks.cdc.gov/view/cdc/261488 ER -
Effectiveness of School Fluoride Delivery Programs: a Community Guide Systematic Review.

Griffin, Susan O ;

Lin, Mei

July 2025 | American Journal of Preventive Medicine, 2025, v. 69, no. 1

Although preventable, dental caries remains highly prevalent. Many children do not receive preventive dental services routinely in clinical settings. This review examined the effectiveness of school (preschool through high school) fluoride varnish delivery programs in preventing caries.Community Guide systematic review methods were followed. In 202 ...

10/09/2026

Supporting Files

Title : Effectiveness of School Fluoride Delivery Programs: a Community Guide Systematic Review. Personal Author(s) : Griffin, Susan O;Lin, Mei;Scherrer, Christina R;Naavaal, Shillpa;Hopkins, David P;Jones, Anita A;Alexander, Tammy;Black, Virginia A;Clark, Elizabeth;Cofano, Lori K;Garcia, Raul I;Goddard, Anna;Grover, Jane;Kansagra, Susan M;Kottke, Thomas E;Lense, Elizabeth C;Zokaie, Tooka; Published Date : July 2025 Pages in Document : 107633 (18 pdf pages) Source : American Journal of Preventive Medicine, 2025, v. 69, no. 1 DOI : https://doi.org/10.1016/j.amepre.2025.04.003 Journal Title : American Journal of Preventive Medicine
Griffin, S. O., Lin, M., Scherrer, C. R., Naavaal, S., Hopkins, D. P., Jones, A. A., Alexander, T., Black, V. A., Clark, E., Cofano, L. K., Garcia, R. I., Goddard, A., Grover, J., Kansagra, S. M., Kottke, T. E., Lense, E. C., & Zokaie, T. (2025). Effectiveness of School Fluoride Delivery Programs: a Community Guide Systematic Review. American Journal of Preventive Medicine, 69(1). https://doi.org/10.1016/j.amepre.2025.04.003

Griffin, Susan O, Mei Lin, Christina R Scherrer, Shillpa Naavaal, David P Hopkins, Anita A Jones, and Tammy Alexander, et al.. "Effectiveness of School Fluoride Delivery Programs: a Community Guide Systematic Review." American Journal of Preventive Medicine 69, no. 1 (2025). https://doi.org/10.1016/j.amepre.2025.04.003.

Griffin, Susan O, et al. "Effectiveness of School Fluoride Delivery Programs: a Community Guide Systematic Review." American Journal of Preventive Medicine, vol. 69, no. 1, 2025. Stacks. https://doi.org/10.1016/j.amepre.2025.04.003.
Export RIS Citation Information. TY - Journal Article AU - Griffin, Susan O AU - Lin, Mei AU - Scherrer, Christina R AU - Naavaal, Shillpa AU - Hopkins, David P AU - Jones, Anita A AU - Alexander, Tammy AU - Black, Virginia A AU - Clark, Elizabeth AU - Cofano, Lori K AU - Garcia, Raul I AU - Goddard, Anna AU - Grover, Jane AU - Kansagra, Susan M AU - Kottke, Thomas E AU - Lense, Elizabeth C AU - Zokaie, Tooka AB - Although preventable, dental caries remains highly prevalent. Many children do not receive preventive dental services routinely in clinical settings. This review examined the effectiveness of school (preschool through high school) fluoride varnish delivery programs in preventing caries. AB - Community Guide systematic review methods were followed. In 2024, databases were searched for studies published through December 2023 on school flouride varnish delivery program effectiveness in increasing fluoride varnish receipt and decreasing caries. Included studies had to be written in English, published in peer-reviewed journals, and conducted in upper-middle- or high-income countries. Data synthesis conducted in 2024 used median RR and interquartile interval (IQI) to summarize findings across studies. AB - Of 31 included studies with 60,780 students, 25 were randomized controlled trials-20 with good quality of execution. Most studies were conducted in low socioeconomic status areas among students at elevated caries risk. School flouride varnish delivery programs reduced caries initiation by 32% (IQI: 21%, 37%) in permanent teeth (19 studies, 25,826 students) and by 25% (IQI: 4%, 37%) in primary teeth (12 studies, 4,304 students). Stratified assessments indicated findings were largely applicable to different settings, populations, and intervention characteristics. Two studies found school flouride varnish delivery programs significantly increased the number of annual flouride varnish applications and 2 found that school flouride varnish delivery program effectiveness was inversely related to socioeconomic status. AB - About 30% of states report having no school flouride varnish delivery programs. Possible barriers to implementation include that Medicaid in some states only reimburses dental and medical professionals and does not reimburse non-dental providers for flouride varnish delivered to children older than age 6 years. AB - Author manuscript AN - cdc:261487 C4 - PMC12185235 DO - https://doi.org/10.1016/j.amepre.2025.04.003 IS - 1 J2 - American Journal of Preventive Medicine KW - Cariostatic Agents KW - Adolescent KW - Child KW - Schools KW - Randomized Controlled Trials as Topic KW - Fluorides, Topical KW - Dental Caries KW - School Health Services KW - Humans KW - Child, Preschool KW - Humans KW - Dental Caries KW - Fluorides, Topical KW - Child KW - School Health Services KW - Child, Preschool KW - Schools KW - Cariostatic Agents KW - Adolescent KW - Randomized Controlled Trials as Topic LA - eng PY - 2025 T2 - American Journal of Preventive Medicine T2 - American Journal of Preventive Medicine, 2025, v. 69, no. 1 TI - Effectiveness of School Fluoride Delivery Programs: a Community Guide Systematic Review. VL - 69 UR - https://stacks.cdc.gov/view/cdc/261487 ER -
Understanding Patient Experience With Past Barriers to Eye Care and How Barriers Were Addressed in the Michigan Screening and Intervention For Glaucoma and Eye Health Through Telemedicine Program.

Webber, Emily ;

Lu, Ming-Chen

August 2025 | American Journal of Ophthalmology, 2025, v. 276

To use community engaged research to understand barriers to eye care utilization and explore participant experiences with free glaucoma screenings through the Michigan Screening and Intervention for Glaucoma and eye Health through Telemedicine (MI-SIGHT) program.Qualitative study.Purposive sampling of 42 participants out of 254 total participants f ...

10/09/2026

Supporting Files

Title : Understanding Patient Experience With Past Barriers to Eye Care and How Barriers Were Addressed in the Michigan Screening and Intervention For Glaucoma and Eye Health Through Telemedicine Program. Personal Author(s) : Webber, Emily;Lu, Ming-Chen;Woodward, Maria A.;Elam, Angela;Bicket, Amanda;Dougherty Wood, Sarah;John, Denise;Johnson, Leroy;Kershaw, Martha;Heisler, Michele;Newman-Casey, Paula Anne; Published Date : August 2025 Pages in Document : 157-169 (24 pdf pages) Source : American Journal of Ophthalmology, 2025, v. 276 DOI : https://doi.org/10.1016/j.ajo.2025.04.007 Journal Title : American Journal of Ophthalmology
Webber, E., Lu, M. C., Woodward, M. A., Elam, A., Bicket, A., Dougherty Wood, S., John, D., Johnson, L., Kershaw, M., Heisler, M., & Newman-Casey, P. A. (2025). Understanding Patient Experience With Past Barriers to Eye Care and How Barriers Were Addressed in the Michigan Screening and Intervention For Glaucoma and Eye Health Through Telemedicine Program. American Journal of Ophthalmology, 276. https://doi.org/10.1016/j.ajo.2025.04.007

Webber, Emily, Ming-Chen Lu, Maria A. Woodward, Angela Elam, Amanda Bicket, Sarah Dougherty Wood, and Denise John, et al.. "Understanding Patient Experience With Past Barriers to Eye Care and How Barriers Were Addressed in the Michigan Screening and Intervention For Glaucoma and Eye Health Through Telemedicine Program." American Journal of Ophthalmology 276 (2025). https://doi.org/10.1016/j.ajo.2025.04.007.

Webber, Emily, et al. "Understanding Patient Experience With Past Barriers to Eye Care and How Barriers Were Addressed in the Michigan Screening and Intervention For Glaucoma and Eye Health Through Telemedicine Program." American Journal of Ophthalmology, vol. 276, 2025. Stacks. https://doi.org/10.1016/j.ajo.2025.04.007.
Export RIS Citation Information. TY - Journal Article AU - Webber, Emily AU - Lu, Ming-Chen AU - Woodward, Maria A. AU - Elam, Angela AU - Bicket, Amanda AU - Dougherty Wood, Sarah AU - John, Denise AU - Johnson, Leroy AU - Kershaw, Martha AU - Heisler, Michele AU - Newman-Casey, Paula Anne AB - To use community engaged research to understand barriers to eye care utilization and explore participant experiences with free glaucoma screenings through the Michigan Screening and Intervention for Glaucoma and eye Health through Telemedicine (MI-SIGHT) program. AB - Qualitative study. AB - Purposive sampling of 42 participants out of 254 total participants from 2 community clinics in Flint and Ypsilanti, Michigan enrolled between 10/29/21 and 12/22/21. AB - We conducted semi-structured interviews that explored past barriers to eye care, motivations for attending and overall experience with the MI-SIGHT program. Interviews were transcribed then coded using Grounded Theory; and thematic analysis was completed. AB - Themes were compared between (1) the 2 clinics; (2) those who did and did not screen positive for glaucoma; and (3) of those who screened positive for glaucoma, comparing between those randomized to standard care and those randomized to personalized coaching and education. AB - The most common past barriers to eye care included cost, insurance status, and transportation. Motivations to attending glaucoma screenings with the MI-SIGHT program included affordability, location of community clinics, and having a trusted referral source endorse the program. Overall, participants most valued the rapport and communication received when interacting with the ophthalmic technicians who also acted as care navigators as part of MI-SIGHT. AB - The MI-SIGHT program was able to address barriers such as cost and transportation through having free eye screenings located at the community clinic. Developing trust and rapport with the participants and the community clinics was critical to the program's high satisfaction rates. AB - Author manuscript AN - cdc:261486 C4 - PMC12245581 DO - https://doi.org/10.1016/j.ajo.2025.04.007 J2 - American Journal of Ophthalmology KW - Female KW - Qualitative Research KW - Glaucoma KW - Mass Screening KW - Male KW - Aged KW - Humans KW - Middle Aged KW - Health Services Accessibility KW - Adult KW - Telemedicine KW - Patient Acceptance of Health Care KW - Community-engaged research KW - screening KW - glaucoma KW - barriers to eye care KW - Humans KW - Telemedicine KW - Male KW - Glaucoma KW - Female KW - Health Services Accessibility KW - Middle Aged KW - Aged KW - Patient Acceptance of Health Care KW - Qualitative Research KW - Mass Screening KW - Adult LA - eng PY - 2025 T2 - American Journal of Ophthalmology T2 - American Journal of Ophthalmology, 2025, v. 276 TI - Understanding Patient Experience With Past Barriers to Eye Care and How Barriers Were Addressed in the Michigan Screening and Intervention For Glaucoma and Eye Health Through Telemedicine Program. VL - 276 UR - https://stacks.cdc.gov/view/cdc/261486 ER -
The Incidence of Neonatal Herpes Simplex Virus Infections in the United States: 2019.

Pooser, Matthew ;

Yuan, Yan

May 2025 | Pediatrics, 2025, v. 155, no. 5

The objective of this study was to generate updated estimates for the incidence rate, cost burden, and case fatality rate (CFR) of neonatal herpes simplex virus (nHSV) infections in the US in 2019.A nationally representative sample of US pediatric discharges was assessed using data from the Healthcare Cost and Utilization Project Kids' Inpatient Da ...

10/09/2026

Supporting Files

Title : The Incidence of Neonatal Herpes Simplex Virus Infections in the United States: 2019. Personal Author(s) : Pooser, Matthew;Yuan, Yan;Karki, Saugat;O'Callaghan, Kevin;Hufstetler, Kaitlin;Perez, Alejandro;Berro, Andre;Chesson, Harrell;Kreisel, Kristen M.; Published Date : May 2025 Pages in Document : e2024067348(18 pdf pages) Source : Pediatrics, 2025, v. 155, no. 5 DOI : https://doi.org/10.1542/peds.2024-067348 Journal Title : Pediatrics
Pooser, M., Yuan, Y., Karki, S., O'Callaghan, K., Hufstetler, K., Perez, A., Berro, A., Chesson, H., & Kreisel, K. M. (2025). The Incidence of Neonatal Herpes Simplex Virus Infections in the United States: 2019. Pediatrics, 155(5). https://doi.org/10.1542/peds.2024-067348

Pooser, Matthew, Yan Yuan, Saugat Karki, Kevin O'Callaghan, Kaitlin Hufstetler, Alejandro Perez, Andre Berro, Harrell Chesson, and Kristen M. Kreisel. "The Incidence of Neonatal Herpes Simplex Virus Infections in the United States: 2019." Pediatrics 155, no. 5 (2025). https://doi.org/10.1542/peds.2024-067348.

Pooser, Matthew, et al. "The Incidence of Neonatal Herpes Simplex Virus Infections in the United States: 2019." Pediatrics, vol. 155, no. 5, 2025. Stacks. https://doi.org/10.1542/peds.2024-067348.
Export RIS Citation Information. TY - Journal Article AU - Pooser, Matthew AU - Yuan, Yan AU - Karki, Saugat AU - O'Callaghan, Kevin AU - Hufstetler, Kaitlin AU - Perez, Alejandro AU - Berro, Andre AU - Chesson, Harrell AU - Kreisel, Kristen M. AB - The objective of this study was to generate updated estimates for the incidence rate, cost burden, and case fatality rate (CFR) of neonatal herpes simplex virus (nHSV) infections in the US in 2019. AB - A nationally representative sample of US pediatric discharges was assessed using data from the Healthcare Cost and Utilization Project Kids' Inpatient Database to estimate the incidence, costs, and fatality of nHSV in 2019. Cases were estimated using herpes simplex virus International Classification of Diseases, Tenth Revision, Clinical Modification codes (B00.xx, A60.xx, or P35.2) among infants aged 28 days or younger admitted to the hospital and with hospital stays more than 5 days or resulting in death. A matching algorithm was developed to deduplicate records of readmissions or transfers from another hospital. Estimates were generated overall and by sociodemographic factors including race, US region, primary payer, and median household income. AB - In total, 561 nHSV cases were estimated in the US in 2019, resulting in an incidence rate of 15.7 per 100 000 hospital births. The highest incidence rate was in the South (21.3; 95% confidence interval [CI], 19.0-23.9) and in infants born to Black birth parents (27.3; 95% CI, 22.8-32.4). The total cost to the US health care system was estimated at $28.9 million. The CFR among infants with nHSV was estimated to be 4.6%. AB - This study updates the incidence rate, cost burden, and CFR of nHSV in 2019, an increase compared with past estimates, and highlights the racial and geographic disparities across the US. Public health interventions for early detection and prevention are critical to mitigate these disparities. AB - Author manuscript AN - cdc:261485 C4 - PMC12088598 DO - https://doi.org/10.1542/peds.2024-067348 IS - 5 J2 - Pediatrics KW - Pregnancy Complications, Infectious KW - Female KW - Herpes Simplex KW - Infant KW - Incidence KW - Male KW - Humans KW - Infant, Newborn KW - Humans KW - Incidence KW - Infant, Newborn KW - Herpes Simplex KW - Female KW - Male KW - Pregnancy Complications, Infectious KW - Infant LA - eng PY - 2025 T2 - Pediatrics T2 - Pediatrics, 2025, v. 155, no. 5 TI - The Incidence of Neonatal Herpes Simplex Virus Infections in the United States: 2019. VL - 155 UR - https://stacks.cdc.gov/view/cdc/261485 ER -
Factors Associated With Intent to Leave the Nursing Profession in the United States: an Integrative Review.

Leep-Lazar, Kathryn ;

Ma, Chenjuan

August 2025 | Research in Nursing & Health, 2025, v. 48, no. 4

The ongoing regional nursing shortages in the United States, exacerbated by the COVID-19 pandemic, compromise patient safety and quality. Additionally, an aging workforce coupled with an aging population requiring more nursing care services limits organizations' ability to adequately staff their facilities. Nurses' turnover from the profession has ...

10/09/2026

Supporting Files

Title : Factors Associated With Intent to Leave the Nursing Profession in the United States: an Integrative Review. Personal Author(s) : Leep-Lazar, Kathryn;Ma, Chenjuan;Stimpfel, Amy Witkoski; Published Date : August 2025 Pages in Document : 429-440 (29 pdf pages) Source : Research in Nursing & Health, 2025, v. 48, no. 4 DOI : https://doi.org/10.1002/nur.22465 Journal Title : Research in Nursing & Health
Leep-Lazar, K., Ma, C., & Stimpfel, A. W. (2025). Factors Associated With Intent to Leave the Nursing Profession in the United States: an Integrative Review. Research in Nursing & Health, 48(4). https://doi.org/10.1002/nur.22465

Leep-Lazar, Kathryn, Chenjuan Ma, and Amy Witkoski Stimpfel. "Factors Associated With Intent to Leave the Nursing Profession in the United States: an Integrative Review." Research in Nursing & Health 48, no. 4 (2025). https://doi.org/10.1002/nur.22465.

Leep-Lazar, Kathryn, et al. "Factors Associated With Intent to Leave the Nursing Profession in the United States: an Integrative Review." Research in Nursing & Health, vol. 48, no. 4, 2025. Stacks. https://doi.org/10.1002/nur.22465.
Export RIS Citation Information. TY - Journal Article AU - Leep-Lazar, Kathryn AU - Ma, Chenjuan AU - Stimpfel, Amy Witkoski AB - The ongoing regional nursing shortages in the United States, exacerbated by the COVID-19 pandemic, compromise patient safety and quality. Additionally, an aging workforce coupled with an aging population requiring more nursing care services limits organizations' ability to adequately staff their facilities. Nurses' turnover from the profession has been studied less than organizational turnover, thus, the purpose of this integrative review is to identify factors associated with intention to leave the nursing profession in the United States. Using Whittemore and Knafl's (2005) guidelines for integrative review methods, we conducted systematic searches in CINAHL, PubMed, and Web of Science in July 2024. There were 39 peer-reviewed studies that met inclusion criteria. Synthesis of findings resulted in four individual and four work-level themes associated with intent to leave the nursing profession. Individual themes included individual beliefs, health and wellbeing, individual work experiences, and career stability. Work-level themes included job characteristics, job demands/workload, resources and support, and work environment. Notably, job-level factors (i.e., workload, work environment, and support) were associated with professional turnover intention, which suggests that nurses do not believe their experiences will improve at another nursing job. Gaps in the literature include studies with nationally representative samples, studies using validated measures of health, and qualitative studies conducted with the aim of understanding why nurses want to leave the profession. To promote retention of nurses at the professional and organizational level, organizations should measure and modify relevant job-level factors, and the protection of nurses' wellness should be a top organizational priority. AB - Author manuscript AN - cdc:261484 C4 - PMC13379930 DO - https://doi.org/10.1002/nur.22465 IS - 4 J2 - Research in Nursing & Health KW - Personnel Turnover KW - Workload KW - Intention KW - Humans KW - COVID-19 KW - Job Satisfaction KW - Workplace KW - United States KW - Humans KW - United States KW - Personnel Turnover KW - Job Satisfaction KW - COVID-19 KW - Intention KW - Workplace KW - Workload LA - eng PY - 2025 T2 - Research in Nursing & Health T2 - Research in Nursing & Health, 2025, v. 48, no. 4 TI - Factors Associated With Intent to Leave the Nursing Profession in the United States: an Integrative Review. VL - 48 UR - https://stacks.cdc.gov/view/cdc/261484 ER -
Interior-point Methods For Monotone Linear Complementarity Problems Based on the New Kernel Function With Applications to Control Tabular Adjustment Problem.

Lesaja, Goran ;

Oganian, Anna

April 11, 2025 | Statistics, Optimization & Information Computing, 2025, v. 13, no. 3

We present a feasible kernel-based interior point method (IPM) to solve the monotone linear complementarity problem (LCP) which is based on an eligible kernel function with a new logarithmic barrier term. This kernel function defines the new search direction and the neighborhood of the central path. We show the global convergence of the algorithm a ...

10/09/2026

Supporting Files

Title : Interior-point Methods For Monotone Linear Complementarity Problems Based on the New Kernel Function With Applications to Control Tabular Adjustment Problem. Personal Author(s) : Lesaja, Goran;Oganian, Anna;Williams, Tifani;Iacob, Ionut;Iqbal, Mehtab; Published Date : April 11, 2025 Pages in Document : 900-921 (35 pdf pages) Source : Statistics, Optimization & Information Computing, 2025, v. 13, no. 3 DOI : https://doi.org/10.19139/soic-2310-5070-2322 Journal Title : Statistics, Optimization & Information Computing
Lesaja, G., Oganian, A., Williams, T., Iacob, I., & Iqbal, M. (2025). Interior-point Methods For Monotone Linear Complementarity Problems Based on the New Kernel Function With Applications to Control Tabular Adjustment Problem. Statistics, Optimization & Information Computing, 13(3). https://doi.org/10.19139/soic-2310-5070-2322

Lesaja, Goran, Anna Oganian, Tifani Williams, Ionut Iacob, and Mehtab Iqbal. "Interior-point Methods For Monotone Linear Complementarity Problems Based on the New Kernel Function With Applications to Control Tabular Adjustment Problem." Statistics, Optimization & Information Computing 13, no. 3 (2025). https://doi.org/10.19139/soic-2310-5070-2322.

Lesaja, Goran, et al. "Interior-point Methods For Monotone Linear Complementarity Problems Based on the New Kernel Function With Applications to Control Tabular Adjustment Problem." Statistics, Optimization & Information Computing, vol. 13, no. 3, 2025. Stacks. https://doi.org/10.19139/soic-2310-5070-2322.
Export RIS Citation Information. TY - Journal Article AU - Lesaja, Goran AU - Oganian, Anna AU - Williams, Tifani AU - Iacob, Ionut AU - Iqbal, Mehtab AB - We present a feasible kernel-based interior point method (IPM) to solve the monotone linear complementarity problem (LCP) which is based on an eligible kernel function with a new logarithmic barrier term. This kernel function defines the new search direction and the neighborhood of the central path. We show the global convergence of the algorithm and derive the iteration bounds for short- and long-step versions of the algorithm. We applied the method to solve a continuous Control Tabular Adjustment (CTA) problem which is an important Statistical Disclosure Limitation (SDL) model for protection of tabular data. Numerical results on a test example show that this algorithm is a viable option to the existing methods for solving continuous CTA problems. We also apply the algorithm to the set of randomly generated monotone LCPs showing that the initial implementation performs well on these instances of LCPs. However, this limited numerical testing is done for illustration purposes; an extensive numerical study is necessary to draw more definite conclusions on the behavior of the algorithm. AB - Author manuscript AN - cdc:261483 C4 - PMC11987674 DO - https://doi.org/10.19139/soic-2310-5070-2322 IS - 3 J2 - Statistics, Optimization & Information Computing KW - Models, Statistical KW - Linear Complementarity Problem KW - Short-step and Long-step Interior-Point Methods KW - Iteration Bounds KW - Polynomial Complexity KW - Control Tabular Adjustment Problem KW - 90C33 KW - 90C51 KW - Models, Statistical LA - eng PY - 2025 T2 - Statistics, Optimization & Information Computing T2 - Statistics, Optimization & Information Computing, 2025, v. 13, no. 3 TI - Interior-point Methods For Monotone Linear Complementarity Problems Based on the New Kernel Function With Applications to Control Tabular Adjustment Problem. VL - 13 UR - https://stacks.cdc.gov/view/cdc/261483 ER -

Previous Page Previous

761 - 780 / 1969

Next Page Next

Found an issue?

Send us an email at: publishinghd@cdc.gov